LabCompass

Thomas W. Wakefield

Medicine · University of Michigan

OpenAlex ORCID
Established · publishing since 1983
Venous Thromboembolism Diagnosis and ManagementDiagnosis and Treatment of Venous DiseasesBlood Coagulation and Thrombosis MechanismsCentral Venous Catheters and HemodialysisAtrial Fibrillation Management and Outcomes

Publications

488

Citations

26,877

Est. group size

~18

Recurring co-author estimate

Active years

44

Publishing since 1983

In context
Among 4,953 established Medicine PIs within our index
Citations: 26,877cohort median 2,544
Publications / year (recent): 7.8cohort median 4.8

Typically publishes in teams of ~4 · 37% small-team papers (≤3 authors) · across 10 venues

Publication cadence
Publications per year over the last 10 years — averaging 7.8/year recently
2017: 20 publications20172018: 10 publications182019: 15 publications192020: 18 publications202021: 9 publications212022: 14 publications222023: 9 publications232024: 10 publications242025: 5 publications252026: 1 publication26
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 4 collaborators2018: 1 collaborator2019: 0 collaborators2020: 0 collaborators2021: 2 collaborators2022: 2 collaborators2023: 2 collaborators2024: 0 collaborators2025: 2 collaborators1719212325
Recent publications
Publishes in
  • Journal of Vascular Surgery Venous and Lymphatic Disorders×51
  • Arteriosclerosis Thrombosis and Vascular Biology×7
  • Journal of Vascular Surgery×7
  • Phlebology The Journal of Venous Disease×4
  • Blood×4
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 25, 2026.

Claim or correct this profile